MQR MultiQure S.A.

0.3381USD1.360 PLN · GPW+1.49%Mkt Cap: 76.33M USDP/E: —

MultiQure S.A., a biopharmaceutical company, researches and develops biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the …

Key Statistics

Company
Market Cap76.33M USD
Enterprise Value—
Revenue (TTM)-353.27K USD
Gross Profit-7.21K USD
Net Income (TTM)-2.44M USD
Revenue/Share-0.0080 USD
Last Price0.3381 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees4
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLPRBLG00010
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S-216.06
P/B6.83
EPS (TTM)-3.35 USD
EPS (Forward)—
52W Range
0.32621% of range1.765
52W High1.765 USD
52W Low0.3262 USD
Profitability
Gross Margin0.00%
Oper. Margin360.17%
EBITDA Margin0.00%
Profit Margin0.00%
ROE69.41%
ROA-198.79%
ROIC-294.21%
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.55M USD
CapEx (TTM)—
FCF Margin3787.61%
FCF Yield-17.53%
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.13
Current Ratio31.74
Quick Ratio—
Book Value/Sh0.05 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.225.75M
Float44.40M
Insiders72.43%
Institutions18.63%
Technical
SMA 500.3937 (-14.1%)
SMA 2000.5620 (-39.8%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)278.18K
Avg Vol (10d)258.02K
Technical Indicators
RSI (14)27.6
MACD-0.2450
MACD Signal-0.2685
MACD Hist.+0.0234
BB Upper0.4134 USD
BB Middle0.3641 USD
BB Lower0.3148 USD
BB Width27.07%
ATR (14)0.0272 USD
Vol Ratio (20d)1.36x

About MultiQure (WSE: MQR)

›

MultiQure (WSE: MQR) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 4 employees.

The shares were at 1.360 PLN on 19 November 2026, down 78.2% over 52 weeks. Its 52-week range is 1.312 PLN to 7.100 PLN: the price is 80.8% below the high and 3.7% above the low.

Its market capitalisation is 307.02M PLN.

MultiQure reports return on equity of 69.4% and an operating margin of 360.2%.

Its Piotroski F-score is 4 out of 9, an average reading of its financial health.